Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Trial 3 Results at Week 26 in a Trial of RYBELSUS Compared to Sitagliptin 100 mg Once Daily in Adult Patients with Type 2 Diabetes Mellitus in Combination with Metformin or Metformin with Sulfonylurea a The intent-to-treat population includes all randomized patients
Factors such as individual metabolism, commitment to lifestyle adjustments, and overall health status play a critical role in determining how effective either medication will be for a particular person
VAL itself is made up of several databases linkable with the unique identifiers of each patient, and these databases contain individual-level data on age, sex, dispensed prescription drugs, diagnoses, hospitalizations, healthcare consultations, economic transactions, as well as migration and death
More serious but less common risks can include: Gallbladder disease Pancreatitis Worsening of diabetic retinopathy in patients with diabetes Thyroid C-cell tumors observed in animal studies Certain conditions, medications, or risk factors may influence whether a healthcare provider thinks GLP-1s are appropriate for you, so women should review their full medical history with a qualified provider before starting therapy
* Correspondence: Lei Zhang, [email protected]
US$ 25.44
US$ 24.47
US$ 28.62
US$ 27.91
US$ 20.85
US$ 28.32
US$ 25.39
